PubMed

Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.

Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Kim JA, Lee Y, Shin EK.

Diabetes Care. 2006 Feb;29(2):195-201.PMID: 16443859 [PubMed - indexed for MEDLINE]Related articlesFree article

Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.

Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, Kang MH, Ahn TH, Choi IS, Shin EK.

Circulation. 2004 Dec 14;110(24):3687-92. Epub 2004 Nov 29.PMID: 15569835 [PubMed - indexed for MEDLINE]Related articlesFree article

Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.

Koh KK, Han SH, Quon MJ, Yeal Ahn J, Shin EK.

Diabetes Care. 2005 Jun;28(6):1419-24.PMID: 15920062 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

Koh KK, Quon MJ, Han SH, Chung WJ, Lee Y, Shin EK.

Int J Cardiol. 2006 Mar 22;108(1):96-100. Epub 2005 Oct 24.PMID: 16246439 [PubMed - indexed for MEDLINE]Related articles

Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients.

Koh KK, Quon MJ, Lee Y, Han SH, Ahn JY, Chung WJ, Kim JA, Shin EK.

Eur Heart J. 2007 Jun;28(12):1440-7. Epub 2007 May 5.PMID: 17483542 [PubMed - indexed for MEDLINE]Related articlesFree article

Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients.

Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, Kim HS, Shin MS, Ahn TH, Choi IS, Shin EK.

J Am Coll Cardiol. 2003 Sep 3;42(5):905-10.PMID: 12957441 [PubMed - indexed for MEDLINE]Related articles

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia.

Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, Choi IS, Shin EK.

J Am Coll Cardiol. 2005 May 17;45(10):1649-53.PMID: 15893182 [PubMed - indexed for MEDLINE]Related articles

Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes.

Koh KK, Quon MJ, Han SH, Ahn JY, Jin DK, Kim HS, Kim DS, Shin EK.

Hypertension. 2005 Jun;45(6):1088-93. Epub 2005 May 9.PMID: 15883229 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.

Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.

Kidney Int Suppl. 2002 Dec;(82):S47-52.PMID: 12410855 [PubMed - indexed for MEDLINE]Related articles

Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy.

Bönner G; Multicentre Study Group.

Blood Press Suppl. 2008 Dec;2:22-30.PMID: 19203019 [PubMed - indexed for MEDLINE]Related articles

Effects of fenofibrate on lipoproteins, vasomotor function, and serological markers of inflammation, plaque stabilization, and hemostasis.

Kon Koh K, Yeal Ahn J, Hwan Han S, Kyu Jin D, Sik Kim H, Cheon Lee K, Kyun Shin E, Sakuma I.

Atherosclerosis. 2004 Jun;174(2):379-83.PMID: 15136070 [PubMed - indexed for MEDLINE]Related articles

Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.

London G, Schmieder R, Calvo C, Asmar R.

Am J Hypertens. 2006 Jan;19(1):113-21.PMID: 16461202 [PubMed - indexed for MEDLINE]Related articles

A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.

Derosa G, Cicero AF, Ciccarelli L, Fogari R.

Clin Ther. 2003 Jul;25(7):2006-21.PMID: 12946547 [PubMed - indexed for MEDLINE]Related articles

The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.

Han SH, Koh KK, Quon MJ, Lee Y, Shin EK.

Atherosclerosis. 2007 Jan;190(1):205-11. Epub 2006 Feb 28.PMID: 16500662 [PubMed - indexed for MEDLINE]Related articles

Discrepancy between improvement of insulin sensitivity and that of arterial endothelial function in patients receiving antihypertensive medication.

Tomiyama H, Yambe M, Yamada J, Motobe K, Koji Y, Yoshida M, Shiina K, Yamashina A.

J Hypertens. 2007 Apr;25(4):883-9.PMID: 17351383 [PubMed - indexed for MEDLINE]Related articles

Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA; Trial of Preventing Hypertension (TROPHY) Study Investigators.

N Engl J Med. 2006 Apr 20;354(16):1685-97. Epub 2006 Mar 14.PMID: 16537662 [PubMed - indexed for MEDLINE]Related articlesFree article

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group.

J Hypertens. 2003 May;21(5):875-86.PMID: 12714861 [PubMed - indexed for MEDLINE]Related articles

Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.

Rosei EA, Rizzoni D, Muiesan ML, Sleiman I, Salvetti M, Monteduro C, Porteri E; CENTRO (CandEsartaN on aTherosclerotic Risk factors) study investigators.

J Hypertens. 2005 Feb;23(2):435-44.PMID: 15662233 [PubMed - indexed for MEDLINE]Related articles

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.

Schram MT, van Ittersum FJ, Spoelstra-de Man A, van Dijk RA, Schalkwijk CG, Ijzerman RG, Twisk JW, Stehouwer CD.

J Hum Hypertens. 2005 Jun;19(6):429-37.PMID: 15647778 [PubMed - indexed for MEDLINE]Related articles

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.

Derosa G, Cicero AF, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Fassi R, Fogari R.

Clin Ther. 2007 Apr;29(4):602-10.PMID: 17617283 [PubMed - indexed for MEDLINE]Related articles